Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms

Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms

The morbidity and mortality of BCR-ABL-negative myeloproliferative neoplasia (MPN) patients is highly dependent on thrombosis that may be affected by antiphospholipid antibodies (aPLA) and lupus anticoagulant. Our aim was to evaluate the association of the aPLA together with platelet receptor glycop...

Full description

Bibliographic Details
Main Authors: Dambrauskienė Rūta, Gerbutavičius Rolandas, Rudžianskienė Milda, Paukštaitienė Renata, Vitkauskienė Astra, Skrodenienė Erika, Remeikienė Diana, Zaborienė Inga, Juozaitytė Elona
Format: Article
Language:English
Published: De Gruyter 2023-02-01
Series:Open Life Sciences
Subjects:
myeloproliferative neoplasia
thrombosis
antiphospholipid antibodies
platelet polymorphisms
Online Access:https://doi.org/10.1515/biol-2022-0545

Internet

https://doi.org/10.1515/biol-2022-0545

Similar Items